XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Go back to XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary| (NASDAQ: XAIR) | Delayed: 0.43 -0.01 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.44 | 52 Week High | $ | |||
| Open | $0.43 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $ | |||
| Volume | 77,152 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.89 -0.01 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $1.75 | |||
| Open | $2.72 | 52 Week Low | $0.64 | |||
| Day High | $2.89 | P/E | N/A | |||
| Day Low | $2.70 | EPS | $0.00 | |||
| Volume | 5,371 | |||||
